Venture Certified
| 기술평가보증기업(기금) | 2019-03-14 ~ 2021-03-13 | 20190102063 | 2019-03-14 |
| 연구개발유형 | 2021-12-29 ~ 2024-12-28 | 20211229020051 | 2019-03-14 |
| 연구개발유형 | 2024-12-29 ~ 2027-12-28 | 20250204020005 | 2019-03-14 |
Revenue CAGR +5.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 20.1B | 19.2B | 18.0B |
| Operating Profit | 2.3B | 1.3B | 1.3B |
| Net Profit | 2.4B | 1.0B | 1.3B |
| Total Assets | 19.7B | 15.1B | 13.5B |
| Total Liabilities | 8.9B | 8.1B | 7.5B |
| Total Equity | 10.8B | 7.0B | 6.0B |
▲ 8.4%
▲ 76.9%
▲ 63.0%
▼ 31.4%
▲ 27.2%
| Name | Position | Role |
|---|---|---|
| 정혜임 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충청남도 아산시",
"ceo_name": "정혜임",
"certificate": [
{
"cert_number": "20190102063",
"changes": "",
"disclosure_date": "2019-03-14",
"first_cert_date": "2019-03-14",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-03-14 ~ 2021-03-13"
},
{
"cert_number": "20211229020051",
"changes": "",
"disclosure_date": "2021-12-29",
"first_cert_date": "2019-03-14",
"no": "2",
"type": "연구개발유형",
"valid_period": "2021-12-29 ~ 2024-12-28"
},
{
"cert_number": "20250204020005",
"changes": "",
"disclosure_date": "2025-02-04",
"first_cert_date": "2019-03-14",
"no": "3",
"type": "연구개발유형",
"valid_period": "2024-12-29 ~ 2027-12-28"
}
],
"company_name": "더영메디 주식회사",
"corp_no": "164811-*******",
"financials": {
"2022": {
"capital_stock": 50000000,
"cost_of_sales": 834880000,
"current_assets": 1183030000,
"current_liabilities": 42276000,
"gross_profit": 964553000,
"net_income": 125458000,
"net_income_bs": 124192000,
"non_current_assets": 171410000,
"non_current_liabilities": 709543000,
"non_operating_expenses": 15408000,
"non_operating_income": 9868000,
"operating_profit": 130998000,
"revenue": 1799433000,
"sga_expenses": 833555000,
"total_assets": 1354440000,
"total_equity": 602621000,
"total_liabilities": 751819000
},
"2023": {
"capital_stock": 50000000,
"cost_of_sales": 688114000,
"current_assets": 1362312000,
"current_liabilities": 51387000,
"gross_profit": 1227915000,
"net_income": 101827000,
"net_income_bs": 100594000,
"non_current_assets": 149657000,
"non_current_liabilities": 757367000,
"non_operating_expenses": 42669000,
"non_operating_income": 18371000,
"operating_profit": 126125000,
"revenue": 1916029000,
"sga_expenses": 1101790000,
"total_assets": 1511969000,
"total_equity": 703215000,
"total_liabilities": 808754000
},
"2024": {
"capital_stock": 200000000,
"cost_of_sales": 768459000,
"current_assets": 1705042000,
"current_liabilities": 180925000,
"gross_profit": 1244674000,
"net_income": 242020000,
"net_income_bs": 224949000,
"non_current_assets": 260379000,
"non_current_liabilities": 706333000,
"non_operating_expenses": 24272000,
"non_operating_income": 38853000,
"operating_profit": 227439000,
"revenue": 2013133000,
"sga_expenses": 1017235000,
"total_assets": 1965421000,
"total_equity": 1078163000,
"total_liabilities": 887258000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [],
"main_products": "ct 부품",
"phone": "041-338-****",
"years": [
2024,
2023,
2022
]
}